Product Wiki · Recalls · EU Safety Gate (RAPEX)

Jouet en peluche Dragon blanc géant de 150cm, avec corne de licorne… — recall SR/00147/26

EU Safety Gate (RAPEX) · France · 2026-01-23 · Serious risk

As described by EU Safety Gate (RAPEX): Jouet en peluche Dragon blanc géant de 150cm, avec corne de licorne, ptérosaure volant, oreiller din

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/00147/26
Date of alert
2026-01-23
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Choking, Suffocation
Brand
Lissipuppe/Lissidoll
Product category
Toys
Product type
Soft toy
🔴 Serious hazard — Reported risk: The product contains small parts (the eyes of the dragon). A small child could put them in the mouth and choke. Furthermore, the plastic bag of the packaging is too thin. If a child plays with the packaging, the plastic can cover the mouth and nose, causing the child to suffocate.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Warn seller of the risks
Date of entry into force
26/11/2025
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10097405

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.